IQVIA ٢٣ أبريل ٢٠٢٦ The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
FierceBiotech ٢٦ مارس ٢٠٢٦ Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA
IQVIA ١٣ مارس ٢٠٢٦ Expanding Options for Emerging Biopharma in the U.S.: A conversation with Meg Hooton, IQVIA Biotech - IQVIA